Monocyte-Derived Macrophages Are Impaired in Myelodysplastic Syndrome
Background. The myelodysplastic syndrome (MDS) comprises a group of clonal hematopoietic stem cell diseases characterized by cytopenia, dysplasia in one or more of the major myeloid lineages, ineffective hematopoiesis, and increased risk of development of acute myeloid leukemia (AML). Macrophages ar...
Saved in:
Main Authors: | Yu Han, Huaquan Wang, Zonghong Shao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2016/5479013 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased Circulating CD4+CXCR5+ Cells and IgG4 Levels in Patients with Myelodysplastic Syndrome with Autoimmune Diseases
by: Na Xiao, et al.
Published: (2021-01-01) -
Myelodysplastic Syndrome and Autoimmunity: A Case Report of an Unusual Presentation of Myelodysplastic Syndrome
by: Andrea L. Merrill, et al.
Published: (2011-01-01) -
Iron Chelation Therapy in Myelodysplastic Syndromes
by: Emanuela Messa, et al.
Published: (2010-01-01) -
Acquired Myelodysplasia or Myelodysplastic Syndrome: Clearing the Fog
by: Ethan A. Natelson, et al.
Published: (2013-01-01) -
Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis
by: Thomas Luo, et al.
Published: (2021-01-01)